Kewaunee Scientific Corporation (NASDAQ:KEQU) Director Donald F. Shaw acquired 1,000 shares of the company’s stock in a transaction dated Monday, September 11th. The shares were bought at an average price of $27.75 per share, for a total transaction of $27,750.00. Following the purchase, the director now owns 21,000 shares in the company, valued at $582,750. The transaction was disclosed in a document filed with the SEC, which is available at this link.
Kewaunee Scientific Corporation (KEQU) opened at 27.80 on Wednesday. Kewaunee Scientific Corporation has a 12-month low of $20.95 and a 12-month high of $27.90. The company’s 50 day moving average price is $25.68 and its 200-day moving average price is $24.03. The firm has a market capitalization of $75.42 million, a price-to-earnings ratio of 17.36 and a beta of 0.08.
Kewaunee Scientific Corporation (NASDAQ:KEQU) last issued its quarterly earnings results on Tuesday, August 29th. The technology company reported $0.42 EPS for the quarter. The business had revenue of $33.88 million for the quarter. Kewaunee Scientific Corporation had a return on equity of 10.33% and a net margin of 3.23%.
The firm also recently declared a quarterly dividend, which will be paid on Monday, September 25th. Investors of record on Monday, September 11th will be issued a dividend of $0.17 per share. This is a positive change from Kewaunee Scientific Corporation’s previous quarterly dividend of $0.15. This represents a $0.68 dividend on an annualized basis and a yield of 2.45%. The ex-dividend date is Friday, September 8th. Kewaunee Scientific Corporation’s dividend payout ratio (DPR) is 42.77%.
Large investors have recently added to or reduced their stakes in the business. Hancock Holding Co. purchased a new stake in Kewaunee Scientific Corporation in the second quarter worth $203,000. California Public Employees Retirement System purchased a new stake in Kewaunee Scientific Corporation in the second quarter worth $202,000. Vanguard Group Inc. increased its position in Kewaunee Scientific Corporation by 38.0% in the second quarter. Vanguard Group Inc. now owns 59,560 shares of the technology company’s stock worth $1,486,000 after buying an additional 16,400 shares during the last quarter. Northern Trust Corp increased its position in Kewaunee Scientific Corporation by 2.3% in the second quarter. Northern Trust Corp now owns 56,131 shares of the technology company’s stock worth $1,397,000 after buying an additional 1,284 shares during the last quarter. Finally, Seizert Capital Partners LLC increased its position in Kewaunee Scientific Corporation by 18.7% in the second quarter. Seizert Capital Partners LLC now owns 22,118 shares of the technology company’s stock worth $551,000 after buying an additional 3,484 shares during the last quarter. 34.42% of the stock is owned by institutional investors and hedge funds.
Kewaunee Scientific Corporation Company Profile
Kewaunee Scientific Corporation is engaged in the design, manufacture and installation of laboratory, healthcare and technical furniture products. The Company’s products include steel, wood and laminate furniture, fume hoods, biological safety cabinets, laminar flow and ductless hoods, adaptable modular and column systems, moveable workstations and carts, epoxy resin worksurfaces, sinks, and accessories and related design services.
Receive News & Ratings for Kewaunee Scientific Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific Corporation and related companies with MarketBeat.com's FREE daily email newsletter.